Very early-onset inflammatory bowel disease: what is difference from adults

Ying Huang   

Consider the patients and babies for novel biologics when breastfeeding

Hong Yang   

*Clinical considerations influencing the use of biologics in elderly patients with inflammatory bowel disease.

Choon Jin Ooi   

(BA07) Olamkicept, a novel IL-6 trans-signaling Inhibitor, induces rapid clinical improvements in moderate to severe ulcerative colitis: phase 2 study results

Shenghong Zhang   

*(BA08) Development of a machine learning model to distinguish between ulcerative colitis and Crohn’s disease using RNA sequencing data

Soo-Kyung Park   

Coffee Break